AOK PLUS DIE GESUNDHEITSKASSE FR SACHSEN UND THRINGEN
A United Kingdom buyer, with 9 published contracts, worth £0, most recently 6 months ago.
Top 2 suppliers won 100% of awarded value — £0 of £0 across 2 awards.
This contract opportunity involves establishing non-exclusive discount agreements for the drug Fampridine, as per German law. The agreements will be made available through an Open House model, allowing all interested pharmaceutical companies to participate if they meet the requirements. There will b
This contract opportunity involves establishing non-exclusive discount agreements for the medication Beclometasone/Formoterol (ATC Code: R03AK08), excluding the dosage of 100µg/6µg as a metered-dose aerosol. The agreements will be made under an Open-House model, allowing all interested pharmaceutica
This contract opportunity involves establishing non-exclusive discount agreements for pharmaceuticals containing the active ingredients Brinzolamid and Brimonidin (official ATC code: S01EC24) under the German Social Code. The agreements will be made through an Open-House model, allowing all interest
This contract opportunity involves establishing non-exclusive discount agreements for the medication Certolizumab pegol, as per § 130a Abs. 8 SGB V. The agreements will be made under an Open-House model, allowing all interested pharmaceutical companies to participate during the application period, p
This contract opportunity involves establishing non-exclusive discount agreements for the drug Safinamide (ATC Code: N04BD03) under Section 130a (8) of the German Social Code (SGB V). The agreements will be made through an Open House model, allowing all interested pharmaceutical companies to partici
